Standard BioTools Inc. — Revenue by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4fb8ae66-21fb-473f-a21d-47121f0d80ae/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $85.3M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-108326 |
| FY 2024 | $91.0M | 2024-01-01 – 2024-12-31 | evidence 0001193125-26-108326 |
| FY 2023 | $106.3M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-023845 |
| FY 2022 | $97.9M | 2022-01-01 – 2022-12-31 | evidence 0001162194-23-000013 |
| FY 2021 | $130.6M | 2021-01-01 – 2021-12-31 | evidence 0001162194-22-000021 |
| FY 2020 | $138.1M | 2020-01-01 – 2020-12-31 | evidence 0001162194-21-000013 |
| FY 2019 | $117.2M | 2019-01-01 – 2019-12-31 | evidence 0001162194-20-000016 |
| FY 2018 | $113.0M | 2018-01-01 – 2018-12-31 | evidence 0001162194-19-000020 |
| FY 2017 | $101.9M | 2017-01-01 – 2017-12-31 | evidence 0001162194-19-000020 |
| FY 2016 | $104.4M | 2016-01-01 – 2016-12-31 | evidence 0001162194-19-000020 |
| FY 2015 | $114.7M | 2015-01-01 – 2015-12-31 | evidence 0001628280-17-002137 |
| FY 2014 | $116.5M | 2014-01-01 – 2014-12-31 | evidence 0001628280-17-002137 |
| FY 2013 | $70.2M | 2013-01-01 – 2013-12-31 | evidence 0001162194-14-000010 |
| FY 2012 | $51.5M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-103352 |
| FY 2011 | $40.6M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-130255 |
| FY 2010 | $30.5M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-130255 |
| FY 2009 | $23.6M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-130255 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Standard BioTools Inc. — all facts · Net Income · Operating Income